|
|
|
(18.188.40.207)
|
|
Users online: 6537
|
|
|
|
|
|
|
Ijournet
|
|
|
|
|
|
|
An Emerging Therapy for Dengue Kothavale Snehal D.*, Suryawanshi S.S., Patil Sachinkumar V. Ashokrao Mane College of Pharmacy, Peth-Vadgoan. Kolhapur, Maharashtra, India (416112) *Corresponding Author E-mail: snehalkothavale28@gmail.com
Online Published on 09 June, 2022. Abstract This project aims to perform the first molecular and clinical-epidermiological analysis of dengue cases in Divipolis, MG, Brazil. Where Data from 4,110 cases of dengue studied and 190 clinical samples were collected for molecular analysis. In this study, 2.7%of men and 3.0% of the women are submitted in hospital. There was no association between gender and hospital admission according to the study of health ministry fever was present in 82.2% and not present in 100%of cases. Dengue fever is a serious viral disease caused by four closely related serotytpe of the genus flavivirus, which is a family flaviviridae. Several classes of agents are in under investigation as potential antidengue drugs, including direct host modulators, antivirals, and RNA therapeutics. These antidengue drugs in development will be reviewed here. Top Keywords Emerging Therapy, Dengue. Top | | |
|
|
|
|
║ Site map
║
Privacy Policy ║ Copyright ║ Terms & Conditions ║
|
|
|
742,105,519 visitor(s) since 30th May, 2005.
|
|
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
|
|
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.
|